Division of Digestive Diseases, Departments of Medicine and Surgery, University of California Los Angeles School of Medicine, Los Angeles, California.
Department of Medicine, Akron General Medical Center, Akron, Ohio.
Clin Gastroenterol Hepatol. 2016 Jan;14(1):5-12; quiz e9-10. doi: 10.1016/j.cgh.2015.05.001. Epub 2015 May 11.
Nonalcoholic fatty liver disease (NAFLD) is a serious public health concern that affects almost one third of the US population. The prevalence of NAFLD varies among ethnic/racial groups, with the Latin American population being affected disproportionately. The severity of NAFLD also may be greater in the Latino population. The increased prevalence and severity of NAFLD in Latino Americans likely is related to the interplay between issues such as genetic factors, access to health care, or the prevalence of chronic diseases such as metabolic syndrome or diabetes. In this review, we summarize the current literature on the prevalence and risk factors of NAFLD that are seen to be more common in the Latino population in the United States. Finally, we discuss available treatment options, medical and surgical, that are available for NAFLD and how they affect the Latino population. Health care providers need to address modifiable risk factors that impact the natural history as well as treatment outcomes for NAFLD among Latinos. Additional efforts are needed to improve awareness and health care utilization for Latinos.
非酒精性脂肪性肝病(NAFLD)是一个严重的公共卫生问题,影响了近三分之一的美国人口。NAFLD 的患病率在不同种族/族裔群体中有所不同,拉丁裔人群受影响的比例不成比例。拉丁裔人群的 NAFLD 严重程度也可能更高。拉丁裔美国人中 NAFLD 的患病率和严重程度增加可能与遗传因素、获得医疗保健的机会或代谢综合征或糖尿病等慢性疾病的流行等问题相互作用有关。在这篇综述中,我们总结了目前关于美国拉丁裔人群中更为常见的 NAFLD 患病率和危险因素的文献。最后,我们讨论了现有的治疗选择,包括内科和外科治疗,以及它们如何影响拉丁裔人群。医疗保健提供者需要解决影响 NAFLD 自然史和治疗结果的可改变的危险因素。需要做出更多努力来提高拉丁裔人群对 NAFLD 的认识和利用医疗保健。